Investigation of the Permeability of Antiretroviral Drugs Lamivudine and Valganciclovir via Single-Pass Intestinal Perfusion (SPIP) Method

IF 0.7 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Senem Şanlı, Mustafa Sinan Kaynak, Nurullah Sanli, Emine Ertürk Balta
{"title":"Investigation of the Permeability of Antiretroviral Drugs Lamivudine and Valganciclovir via Single-Pass Intestinal Perfusion (SPIP) Method","authors":"Senem Şanlı, Mustafa Sinan Kaynak, Nurullah Sanli, Emine Ertürk Balta","doi":"10.2174/0115734129310868240805065851","DOIUrl":null,"url":null,"abstract":"Introduction: Antiretroviral medications are widely used to treat HIV infections. Lamivudine (3TC) is prescribed for HIV-1 infection management in adults and pediatrics, while valganciclovir (VGC) is a prodrug of ganciclovir derived from valine. Method: The Biopharmaceutics Classification System (BCS) estimates the contributions of intestinal permeability, dissolution, and solubility in oral drug absorption. Intestinal permeability refers to a substance's capacity to pass through the protective layer of cells in the intestine. The intestinal permeability of 3TC and VGC was analyzed and categorized using the single-pass intestinal perfusion technique according to the BCS in male Sprague Dawley rats, and a reversed- phase HPLC method was validated for precise and accurate measurement. objective: Intestinal permeability refers to a substance's capacity to pass through the protective layer of cells in the intestine. Result: According to the BCS, 3TC and VGC have been classified as having low permeability when compared to metoprolol tartrate, which is classified as Class I with good permeability and resolution. Conclusion: The permeability values derived from this work can be valuable in exposure assessment models.","PeriodicalId":10889,"journal":{"name":"Current Pharmaceutical Analysis","volume":"18 1","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmaceutical Analysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115734129310868240805065851","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Antiretroviral medications are widely used to treat HIV infections. Lamivudine (3TC) is prescribed for HIV-1 infection management in adults and pediatrics, while valganciclovir (VGC) is a prodrug of ganciclovir derived from valine. Method: The Biopharmaceutics Classification System (BCS) estimates the contributions of intestinal permeability, dissolution, and solubility in oral drug absorption. Intestinal permeability refers to a substance's capacity to pass through the protective layer of cells in the intestine. The intestinal permeability of 3TC and VGC was analyzed and categorized using the single-pass intestinal perfusion technique according to the BCS in male Sprague Dawley rats, and a reversed- phase HPLC method was validated for precise and accurate measurement. objective: Intestinal permeability refers to a substance's capacity to pass through the protective layer of cells in the intestine. Result: According to the BCS, 3TC and VGC have been classified as having low permeability when compared to metoprolol tartrate, which is classified as Class I with good permeability and resolution. Conclusion: The permeability values derived from this work can be valuable in exposure assessment models.
通过单通道肠道灌注(SPIP)法研究抗逆转录病毒药物拉米夫定和缬更昔洛韦的渗透性
导言:抗逆转录病毒药物被广泛用于治疗艾滋病毒感染。拉米夫定(3TC)是成人和儿童治疗 HIV-1 感染的处方药,而缬更昔洛韦(VGC)是从缬氨酸中提取的更昔洛韦原药。方法:生物制药分类系统(BCS)估算了口服药物吸收过程中肠道渗透性、溶解性和可溶性的贡献。肠道渗透性是指物质通过肠道细胞保护层的能力。根据 BCS,采用单通道肠道灌注技术对雄性 Sprague Dawley 大鼠的 3TC 和 VGC 的肠道渗透性进行了分析和分类,并验证了反相 HPLC 方法的精确性和准确性:肠道渗透性是指物质通过肠道细胞保护层的能力。结果:根据 BCS,3TC 和 VGC 被归类为低渗透性,而酒石酸美托洛尔被归类为 I 级,具有良好的渗透性和分辨率。结论这项工作得出的渗透性值可用于暴露评估模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
85
审稿时长
3 months
期刊介绍: Aims & Scope Current Pharmaceutical Analysis publishes expert reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信